Completed NA INTERVENTIONAL 2-arm NCT04203771

Probiotic Intervention After Surgical Removal of Mandibular Third Molars

Effect of Probiotic Intervention With Lactobacillus Brevis KABP052 (CECT7480) and Lactobacillus Plantarum KABP051 (CECT7481) After Surgical Removal of Mandibular Third Molars: a Randomized, Controlled, Double-blinded Trial

Sponsor: AB Biotics, SA

Conditions Molar, Third Surgery--Complications

Interventions Ibuprofen Placebo Probiotic AB-DENTALAC Surgical removal of mandibular third molars at baseline

Updated 5 times since 2020 Last updated: May 5, 2020 Started: Jun 30, 2016 Primary completion: Apr 30, 2017 Completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Molar, Third and Surgery--Complications and is currently completed. AB Biotics, SA leads this study, which shows 5 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2020 — Jan 2021 [monthly]

Completed NA
Jan 2020 — Jun 2020 [monthly]

Completed NA

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AB Biotics, SA
Hospital de Nens de Barcelona

Data source: AB Biotics, SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain